Apellis Pharmaceuticals, Inc. (APLS)
21.34
-1.86
(-8.00%)
USD |
NASDAQ |
Jan 13, 16:00
21.33
-0.02
(-0.07%)
After-Hours: 20:00
Apellis Pharmaceuticals Price: 21.34 for Jan. 13, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 178.35 |
| Amicus Therapeutics, Inc. | 14.31 |
| Fortress Biotech, Inc. | 3.90 |
| Ultragenyx Pharmaceutical, Inc. | 24.13 |
| Fulcrum Therapeutics, Inc. | 10.26 |
Price Related Metrics
| PE Ratio | 71.87 |
| PS Ratio | 2.657 |
| Price to Book Value | 6.732 |
| Price to Free Cash Flow | 34.34 |
| Earnings Yield | 1.39% |
| Market Cap | 2.701B |
| Operating PE Ratio | 33.59 |
| Normalized PE Ratio | 71.87 |